Literature DB >> 22116704

Vitamin B6 and cardiovascular disease.

Simonetta Friso1, V Lotto, R Corrocher, Sang Woon Choi.   

Abstract

While overt vitamin B6 deficiency is not a frequent finding nowadays in medical practice, evidence suggests that insufficiency of this vitamin is rather widespread in a quite large portion of the population such as the elderly or in not unusual conditions such as that of alcohol addiction. Moreover, a mild deficiency in B6 vitamin is a state that may be associated with an increased risk of cardiovascular disease. Epidemiologic evidence from case control and prospective studies have suggested that low dietary intake or reduced blood concentrations of vitamin B6 is associated with an increased risk of cardiovascular disease, although most recent trials demonstrated the ineffectiveness of vitamin B6 supplementation on the prevention of cardiovascular events recurrence. Due to limited and somewhat inconsistent data together with the ample variety of critical functions in which vitamin B6 is involved in the human body, it is very challenging to attempt at establishing a cause and effect relationship between vitamin B6 and risk of cardiovascular disease as it is to delineate the exact mechanism(s) by which vitamin B6 may modulate such risk. In the present chapter we review the currently available knowledge deriving from both epidemiological and mechanistic studies designed to define potential candidate mechanisms for the association of vitamin B6 impairment and risk of cardiovascular disease development.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22116704     DOI: 10.1007/978-94-007-2199-9_14

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  5 in total

Review 1.  Homocysteine-lowering interventions for preventing cardiovascular events.

Authors:  Arturo J Martí-Carvajal; Ivan Solà; Dimitrios Lathyris; Mark Dayer
Journal:  Cochrane Database Syst Rev       Date:  2017-08-17

2.  Compound amino acid combined with high-dose vitamin B6 attenuate traumatic coagulopathy via inhibiting inflammation by HMGB1/TLR4/NF-κB pathway.

Authors:  Shi-Jian Yi; Yang Wu; Lan-Lan Li; Qian-Kun Liang; Yue Xiao
Journal:  J Inflamm (Lond)       Date:  2020-08-28       Impact factor: 4.981

3.  Application of in vitro bioaccessibility and bioavailability methods for calcium, carotenoids, folate, iron, magnesium, polyphenols, zinc, and vitamins B(6), B(12), D, and E.

Authors:  Paz Etcheverry; Michael A Grusak; Lisa E Fleige
Journal:  Front Physiol       Date:  2012-08-06       Impact factor: 4.566

4.  Modification of vitamin B6 on the associations of blood lead levels and cardiovascular diseases in the US adults.

Authors:  Jia Wei; John S Ji
Journal:  BMJ Nutr Prev Health       Date:  2020-08-12

5.  Cardiovascular safety of celecoxib in rheumatoid arthritis and osteoarthritis patients: A systematic review and meta-analysis.

Authors:  Bai-Ru Cheng; Jia-Qi Chen; Xiao-Wen Zhang; Qin-Yang Gao; Wei-Hong Li; Li-Jiao Yan; Yu-Qiao Zhang; Chang-Jiang Wu; Jing-Li Xing; Jian-Ping Liu
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.